Ignite Creation Date:
2025-12-24 @ 4:57 PM
Ignite Modification Date:
2026-01-04 @ 4:19 PM
Study NCT ID:
NCT01702350
Status:
TERMINATED
Last Update Posted:
2017-06-28
First Post:
2012-09-20
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Four Part Study to Investigate Relative Bioavailability, Safety and Tolerability of up to 5 Oral Formulation of GSK2251052 in Order to Identify a Formulation for Further Evaluation in a Future Later Phase Study
Sponsor:
GlaxoSmithKline
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2011-10-21
Start Date Type:
ACTUAL
Primary Completion Date:
2011-12-08
Primary Completion Date Type:
ACTUAL
Completion Date:
2011-12-08
Completion Date Type:
ACTUAL
First Submit Date:
2012-09-20
First Submit QC Date:
None
Study First Post Date:
2012-10-08
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2017-06-27
Last Update Post Date:
2017-06-28
Last Update Post Date Type:
ACTUAL